TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Colorado unemployment rate edges up to 7.8% in July Colorado employers cut 10,900 jobs in July, a smaller-than-usual decline for the month, while the unemployment rate rose two-tenths of a percentage point to 7.8 percent, the Colorado Department of Labor and Employment said Friday. feeds.bizjournals.com |
One-Dose Flu Vaccine Tests Well One dose of a proposed H1N1 influenza vaccine caused a "robust" immune response in most adults, data from a National Institutes of Health study showed. online.wsj.com |
VaxGen Nominates Director Candidates, Clarifies Rights to AIDS Vaccine Greenbackd submits: It’s been a big week for VaxGen Inc (VXGN.OB). On Tuesday last week the “VaxGen Full Value Committee” nominated five director candidates to the board. Then on Thursday BizJournals.com reported that VXGN’s “failed AIDS vaccine” was “successful in a new trial that combined it with another failed vaccine in reducing the risk of becoming infected with HIV.” The stock ran on the news, prompting VXGN to clarify yesterday that it “retains an option to obtain the exclusive right to manufacture, commercialize, and further develop the HIV vaccine candidates in the U.S., Europe, Japan and other countries that are members of the Organization of Economic Cooperation and Development” but “has no rights or obligations to manufacture or develop the vaccine candidates unless and until it exercises this option.” We’ve been following VXGN (see our post archive here) because it is trading at a substantial discount to its net cash position, has ended its cash-burning product development activities and is “seeking to maximize the value of its remaining assets through a strategic transaction or series of strategic transactions.” Management has said that, if the company is unable to identify and complete an alternate strategic transaction, it proposes to liquidate. One concern of ours has been a lawsuit against VXGN by its landlords, in which they sought $22.4M. That lawsuit was dismissed in May, so the path for VXGN to liquidate has now hopefully cleared. The board has, however, been dragging its feet on the liquidation. Given their relatively high compensation and almost non-existent shareholding, it’s not hard to see why.Complete Story » seekingalpha.com |
Payments Cut for Doctors Using Medical Imaging U.S. federal health regulators announced new rules that will result in trimmed payments for doctors who use expensive medical-imaging machines to screen patients for diseases such as cancer and heart problems. online.wsj.com |
Bright Ideas for Treating Winter Blues There is now hope for sufferers of seasonal affective disorder, which can cause depression, lethargy, irritability and a desire to avoid social situations. online.wsj.com |